|
tri-tert-butyl 3-oxo-4-oxa-1,8,11-triazaspiro(5.6)dodecane-1,8,11-triacetate
|
C549892 |
|
|
6-methyl-B-norandrostenedione
|
C549893 |
|
|
2-amino-8-(2-deoxy-2-fluoroarabinofuranosyl)imidazo(1,2-a)(1,3,5)triazin-4(8H)-one
|
C549894 |
|
|
1-(erythrofuranosyl)adenosine
|
C549895 |
|
|
corynoxine B
|
C000600670 |
|
|
MORC2 protein, human
|
C549896 |
|
|
BTDAN-COX-2
|
C000600671 |
|
|
NUDT16 protein, mouse
|
C549897 |
|
|
Conservative Treatment
|
D000072700 |
[Therapeutic approaches that are limited, gradual, or well-established as opposed to radical methods.
] |
|
imidazo(4,5-b)pyridine
|
C000600672 |
|
|
poly(diethylene glycol ethyl ether acrylate)
|
C535257 |
|
|
pyrazolo(1',5'-1,6)pyrimido(4,5-d)pyridazin-4(3H)-one
|
C000600673 |
|
|
4,4-bis(triethoxysilyl)biphenyl
|
C535258 |
|
|
2-(4-methoxy-phenyl)imidazo(4,5-f)-(1,10)phenanthroline
|
C000600674 |
|
|
bis(5-(4'-n-dodecyloxy benzoyloxy)-2-(4''-methylphenylazo)phenyl) adipate
|
C535259 |
|
|
1,4-benzoxazine-(1,2,3)triazole
|
C000600675 |
|
|
6-((7-nitrobenzo(c)(1,2,5)oxadiazol-4-yl)thio)hexan-1-ol
|
C000600676 |
|
|
1,1'-diethyl-4,4'-bipyridine-1,1'-diium bis(1,1,3,3-tetracyano-2-ethoxypropenide)
|
C000589831 |
|
|
32,33-didehydroroflamycoin
|
C000600677 |
|
|
chaiyaphumine A
|
C000589832 |
|
